Urologix, Inc. (ULGX) Reports Q3 Loss of $0.07/Share; Revs Improve
Tweet
Share
E-mailGet Alerts ULGX Hot Sheet
Price: $0.00 --0%
Financial Fact:
Provision for income tax expense: 0
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Provision for income tax expense: 0
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Urologix, Inc. (NASDAQ: ULGX) reported Q3 EPS of ($0.07), versus ($0.07) reported last year. Revenue for the quarter came in at $4.74 million, versus $2.98 million reported last year.
For earnings history and earnings-related data on Urologix, Inc. (ULGX) click here.
For earnings history and earnings-related data on Urologix, Inc. (ULGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Optimum Communications gets NYSE non-compliance notice over stock price
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
